In the world of career experts, we talk endlessly about The Great Resignation and the gender pay gap, but we often miss the nearly $119 billion leak happening in plain sight. This March, as we recognize Endometriosis Awareness Month, it’s clear that a health crisis has officially turned into an economic one.
While Gen Z is successfully bringing endometriosis into the mainstream conversation, the labor market remains stuck in the past. Our data reveals a staggering reality: over 185,000 Americans are forced to quit their jobs every year because of this condition. "Bad periods," some might say. The truth is much harsher: these are involuntary exits from the workforce.
As career experts, we see the endo tax everywhere—in the 11 hours of lost productivity per week and the "unexplained" resume gaps left behind by a decade-long diagnostic delay. If we want a truly efficient economy, we have to move beyond awareness and start talking about bio-inclusion in the workplace.
The anatomy of the $119 billion endo tax
When we say the U.S. economy loses $119 billion annually, it’s easy to assume those costs are locked away in hospital bills. But as career experts, we know the most damaging costs are the ones that never show up on a medical claim.
Key stats
- $15,797: The estimated average annual cost of lost productivity (presenteeism + absenteeism) for a single employee with endometriosis.
- $160,000+: Estimated lifetime earnings lost for a woman whose career is sidelined during the "invisible" decade of waiting for a diagnosis.
- 10 to 1: For every $1 spent on direct medical care for endometriosis, the economy loses roughly $10 in indirect costs (productivity and job exits).
- Higher toll than migraines & Crohn’s: Studies show the per-patient economic burden of endometriosis is higher than that of chronic migraines or Crohn’s disease, yet it receives significantly less workplace accommodation.
The economic drain of endometriosis is built on three invisible pillars:
Turnover toll ($8.3 billion)
Every time a worker is forced to resign, the clock starts on a very expensive process. Our analysis shows that with 185,312 endometriosis-attributable quits per year, U.S. employers are losing billions in churn. Between recruitment fees, interviewing hours, and the months it takes for a new hire to reach full productivity, replacing a single employee typically costs roughly 33% of their annual salary.
For the American economy, that’s an $8.3 billion self-inflicted wound.
Presenteeism penalty
The largest portion of the $119 billion isn't about people leaving, but the people who stay. Research indicates that workers with endometriosis lose an average of 10.8 hours of productivity per week to presenteeism—being physically at a desk but unable to perform due to debilitating pain. For a company, this is the equivalent of paying for a full-time expert but only receiving three days of work.
Lifetime earnings gap
For the individual, the loss is compounded over a career. Because of the average seven-to-ten year delay in diagnosis, many workers spend their most pivotal career-building years struggling with "unexplained" performance dips. This leads to slower salary growth and missed promotions, effectively creating a health gap that mirrors the more famous gender pay gap.
The 10-year gap: When biology rewrites a resume
- A seven-to-ten year diagnostic delay often hits during peak career-building years, forcing talented workers into survival mode rather than professional growth.
- Many of the 185,000 annual quits are temporary exits. These medical gaps are frequently misread by recruiters as a lack of ambition or reliability.
- Endometriosis patients often experience slower salary growth, trailing peers by thousands in annual earnings as they prioritize "safe," flexible roles over high-growth opportunities.
- Candidates often hide their condition to avoid bias, leading to a "double-bind" where they enter workplaces that lack the health-inclusive policies necessary for their long-term retention.
Industry breakdown: Where the drain hits hardest
When we look at the data by sector, it becomes clear that endometriosis doesn’t strike the economy evenly. By cross-referencing official December 2025 JOLTS labor reports with clinical risk multipliers, our analysis identifies the industries bearing the brunt of these involuntary exits.
The hardest-hit sectors are losing the very backbone of their operations.
Leisure, hospitality, and retail
The service economy is currently the epicenter of the endo-exodus. According to our modeling, leisure and hospitality loses approximately 43,700 workers annually to endometriosis-attributable quits, followed closely by retail trade at 31,000.
In industries defined by long shifts on your feet and rigid scheduling, "pushing through" isn't just difficult—it’s physically impossible. For these sectors, which are already grappling with chronic labor shortages, this represents a massive, preventable loss of experienced staff.
Reality check
We have to be honest: in sectors defined by physical presence and rigid scheduling, policy changes alone aren't enough. For the most severe, treatment-resistant cases, a "return to form" isn't always possible—even with the best medical care.
In these environments, standard HR fixes fail because the role itself is at odds with the worker's biology. Bridging this gap requires permanent structural flexibility and a culture of long-term belief. Without a total reimagining of how these roles function, we risk permanently sidelining some of our most resilient talent.
Health services and education
There’s a profound irony in the data for private education and health services. This sector, dedicated to the well-being of others, loses an estimated 26,100 workers every year to endometriosis. When nurses, teachers, and caregivers are forced to resign because their own health needs aren't met by their employers, the quality of care for everyone else suffers.
Professional and business services
Even in desk-job environments where physical labor isn't the primary barrier, the drain remains high. Our data indicates that professional and business services see over 20,700 quits annually. In these high-skill roles, the cost of turnover is at its peak. Losing a seasoned project manager or consultant costs not only a salary, but also institutional knowledge that takes years to replace.
The endo tax by the numbers
| Metric | Impact | Data and source context |
|---|---|---|
| Annual U.S. economic burden | $119 billion | Estimated 2026 total loss (medical + productivity + turnover). Adjusted for inflation from Soliman et al. (2016) baseline. |
| Annual endo job leavers | 185,312 quits | Calculated by applying a conservative 25% "health-multiplier" to BLS JOLTS (Feb 2026) industry-specific quit rates. |
| Direct turnover cost | $8.3 billion | The immediate corporate cost to recruit and train replacements for the 185k workers forced to exit. |
| Weekly productivity leak | 10.8 hours | Average time lost per employee due to presenteeism, sourced from Journal of Managed Care & Specialty Pharmacy. |
| Diagnostic delay | 7–10 years | The average time between symptom onset and surgical diagnosis (World Endometriosis Society), creating a decade of “hard-to-explain” resume gaps. |
| Hidden salary penalty | Up to $6,600/year | The average annual earnings gap between workers with endometriosis and their peers by year five of their career. |
The solution: Moving toward a health-inclusive workplace
The $119 billion hole in our economy isn't inevitable. But our current workplace models are built for a "standard" biology that doesn’t account for the one in ten workers suffering from endometriosis.
To stop the drain of talent and capital, we have to move beyond awareness and into action.
As career experts, we see three high-impact shifts that turn forced exits into long-term retention:
Normalizing physiological flexibility
The 9-to-5, "butt-in-seat" model is the primary driver of the 185,000 annual quits we identified. By embracing asynchronous work and flex-hours, companies allow employees to work around pain flares rather than through them. When success is measured by output rather than consecutive hours at a desk, the endo tax on productivity begins to disappear.
Redefining the resume gap
Hiring managers need to stop viewing career breaks as red flags. If we want to tap into the massive pool of resilient, high-skill talent currently sidelined by endometriosis, we must train recruiters to see medical sabbaticals as periods of strategic health management. A candidate who’s navigated a 10-year diagnostic delay while maintaining a career isn't unreliable. Quite the opposite—they’re exceptionally resilient.
Building bio-inclusive benefits
Standard health insurance and generic PTO policies often fall short for chronic conditions. Forward-thinking companies are now offering specialized support, such as access to endometriosis specialists (excision surgeons) and flare-up leave that doesn't eat into standard vacation time. These are retention strategies with a massive ROI.
Final thoughts
We can no longer afford a multi-billion-dollar silence. Endometriosis is not a niche health issue. It’s a systemic labor crisis that has been hidden in plain sight for decades. When 185,000 workers are forced to choose between their health and their livelihoods every year, the economy loses its most resilient talent.
Building a health-inclusive culture should be a calculated investment in retention, a hedge against the rising costs of turnover, and a necessary evolution for any organization serious about closing the gender pay gap.
The $119 billion leak is measurable, costly, and—most importantly—often fixable. Modernizing our workplaces to accommodate the 1-in-10 is about equity and basic economic efficiency. If we want a resilient workforce, we have to stop treating biological needs as inconveniences and start treating them as part of the job description.
Our methodology
To be clear, there is no single government census that asks, "Did you quit because of endometriosis?" To find these answers, we had to build a bridge.
Оur data team developed a multi-stage economic model:
- Baseline labor data: We used the Bureau of Labor Statistics (BLS) Job Openings and Labor Turnover Survey (JOLTS) from December 2025 and February 2026 to establish sector-specific quit rates across the U.S. economy.
- Health multiplier: We integrated clinical findings from the HR 2.01 Work-Loss Risk Study, which identifies that individuals with endometriosis face a significantly higher risk of involuntary workforce exit.
- Conservative modeling: While clinical data suggests a 2x risk (100% increase), our base scenario uses a weighted 25% attribution multiplier. This accounts for the 1-in-10 prevalence of the condition within the female-identifying workforce (ages 20-54), ensuring our $119B estimate remains a conservative floor rather than a speculative ceiling.
- Turnover valuation: Costs for the turnover toll ($8.3B) were calculated using the industry-standard SHRM benchmark (33% of average annual salary per lost employee) applied to our projected 185,312 annual quits.
Make one that's truly you.
